FDA approves first RSV vaccine for at-risk adults in their 50s
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, ...
Tag: 50s
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, ...
